GW406381

DRUG5 trials

Sponsors

GlaxoSmithKline

Conditions

Arthritis, RheumatoidDental PainHyperalgesiaNeurodyniaOsteoarthritis, KneePainSurgery, DentalTrauma

Phase 1

GW406381 In Patients With Peripheral Nerve Injury

CompletedNCT00279032

GlaxoSmithKlineHyperalgesia, Neurodynia, Pain +1

Start: 2003-09-30Target: 40Updated: 2009-02-23

A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment

CompletedNCT00373243

GlaxoSmithKlinePain

Start: 2005-10-19End: 2006-09-26Updated: 2017-09-11

Phase 3

COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

CompletedNCT00113308

GlaxoSmithKlineArthritis, Rheumatoid

Start: 2005-06-30End: 2006-09-30Updated: 2017-03-14

Dental Pain (Following Third Molar Tooth Extraction) Study

CompletedNCT00114049

GlaxoSmithKlineDental Pain, Surgery, Dental

Start: 2004-12-31End: 2005-04-30Target: 300Updated: 2017-01-19

Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee

CompletedNCT00120900

GlaxoSmithKlineOsteoarthritis, Knee

Start: 2005-05-31End: 2007-09-30Updated: 2017-01-19